Does peritransplantation use of rituximab reduce the risk of EBV reactivation and PTLPD?

Savani, Bipin N; Pohlmann, Paula R; Jagasia, Madan; Chinratanalab, Wichai; Kassim, Adetola; Engelhardt, Brian; Greer, John; Schuening, Friedrich; Goodman, Stacey (2009). Does peritransplantation use of rituximab reduce the risk of EBV reactivation and PTLPD? Blood, 113(24), pp. 6263-4. Washington, D.C.: American Society of Hematology 10.1182/blood-2009-04-213892

Full text not available from this repository.

Item Type:	Journal Article (Further Contribution)
ISSN:	0006-4971
Publisher:	American Society of Hematology
Language:	English
Submitter:	Factscience Import
Date Deposited:	04 Oct 2013 15:13
Last Modified:	04 May 2014 23:23
Publisher DOI:	10.1182/blood-2009-04-213892
PubMed ID:	19520823
Web of Science ID:	000267147100037
URI:	https://boris.unibe.ch/id/eprint/32141 (FactScience: 197068)